Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.

Scarlett KA, White EZ, Coke CJ, Carter JR, Bryant LK, Hinton CV.

Mol Cancer Res. 2018 Jan 12. pii: molcanres.0481.2017. doi: 10.1158/1541-7786.MCR-16-0481. [Epub ahead of print]

PMID:
29330286
2.

Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.

Coke CJ, Scarlett KA, Chetram MA, Jones KJ, Sandifer BJ, Davis AS, Marcus AI, Hinton CV.

J Biol Chem. 2016 May 6;291(19):9991-10005. doi: 10.1074/jbc.M115.712661. Epub 2016 Feb 3.

Supplemental Content

Support Center